GILD: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/90d7ec2e-85c8-4e32-984a-1edea46d959e/","filing_uuid":"90d7ec2e-85c8-4e32-984a-1edea46d959e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/90d7ec2e-85c8-4e32-984a-1edea46d959e/print/","filing_document_content_type":"text/html","income":"150000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jeffrey Miller","dt_posted":"2026-07-20T12:45:33-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"P.O. Box 625","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Buda","registrant_state":"TX","registrant_zip":"78610","registrant":{"id":401104313,"url":"https://lda.gov/api/v1/registrants/401104313/","house_registrant_id":null,"name":"MILLER STRATEGIES, LLC","description":"strategic public affairs","address_1":"P.O. Box 625","address_2":null,"address_3":null,"address_4":null,"city":"Buda","state":"TX","state_display":"Texas","zip":"78610","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEFFREY MILLER","contact_telephone":"+1 202-434-8242","dt_updated":"2026-07-30T15:40:39.312430-04:00"},"client":{"id":66842,"url":"https://lda.gov/api/v1/clients/66842/","client_id":66842,"name":"GILEAD SCIENCES, INC.","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to pharmaceuticals and drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65463,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69623,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"GUNN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149246,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"MIN","suffix":null,"suffix_display":null},"covered_position":"\\","new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":18,"name":"Office of Management & Budget (OMB)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to pharmaceuticals and drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65463,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69623,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"GUNN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149246,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"MIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":18,"name":"Office of Management & Budget (OMB)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to pharmaceuticals and drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65463,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69623,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"GUNN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149246,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"MIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":18,"name":"Office of Management & Budget (OMB)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}